Low Level Laser Therapy to Reduce Pain After Breast Augmentation Surgery

Inclusion Criteria: * Suitability for breast augmentation surgery based on the need for correction of a congenital deformity or condition such as: Amastia, Hypomastia, Hypoplasia, Pectus Carinatum, Pectus Excavatum, OR a cosmetic breast enhancement indication, including: Augmentation to increase breast size, correction of ptotic (drooping) or pendulous (sagging) breasts, recontouring to obtain enhanced breast shape. * Bilateral breast augmentation indication only. * 18 to 55 years, inclusive. * Female, only. * Willingness, and ability, to refrain from consuming over-the-counter and/or prescription medications for the indication of the relief of pain and/or swelling, including any non-steroidal anit-inflammatory drugs (NSAIDs), from 48 hours immediately prior to the laser-assisted breast implant procedure through to one week post-procedure. Exclusion Criteria: * Breast augmentation procedures indicated for the purpose of breast reconstruction following mastectomy or an injury due to severe trauma. * Presence of a specific connective tissue disorder. * Inadequate tissue available to cover the implants. * Consumption of any one or more of narcotics, opiates, and/or steroids. * Inability to consume the following medications post-operatively due to allergy, intolerance, or any other reason: (i) Pain medication for the relief of post-operative pain of Lortab 10/500 or another drug within the combination narcotic analgesic drug category within which Lortab falls. (ii) Antibiotic medication for reducing the risk of post-operative infection of Keflex 500 mg or Cipro 500 mg or another drug within the broad-spectrum antibiotic drug category within which Keflex and Cipro fall. * Developmental disability or cognitive impairment that impacts a subject's ability to read and/or to understand the content of the informed consent form, and/or impacts a subject's ability to read and /or to understand and/or to complete the required case report form information for the clinical study. * Significant psychological disorder(s) for which treatment has become necessary, including anxiety and depression; psychiatric hospitalization. * Pregnancy or lactation. * Prior surgery to the breast area, or to the area of the intended incision. * Infection or wound in the intended areas of treatment. * Involvement in litigation and/or receiving disability benefits related to the subject's breast(s). * Participation in research over the preceding 90 days.